2 ASX All Ords shares soaring on strong full year results

These shares are making their shareholders smile on Friday. Let's find out why.

| More on:
Ecstatic woman looking at her phone outside with her fist pumped.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Earnings season has continued to heat up on Friday with another set of result releases.

Two ASX All Ords shares that have released strong full year results today are listed below. Let's see what they reported:

AVITA Medical Inc (ASX: AVH)

The AVITA Medical share price is up 10% to $3.05.

This morning, the medical device company released its fourth quarter and full year results.

The ASX All Ords share reported a 30% increase in commercial revenue to US$18.4 million for the fourth quarter. This took commercial revenue to US$64 million for the full year, which is an increase of approximately 29% compared to the same period a year ago.

Its fourth quarter gross margin came in at 87.6%, which lifted its full year gross profit margin to 85.8%.

However, this couldn't stop the company from reporting a net loss of US$61.8 million for the year. This is up from US$35.4 million in FY 2023. Management advised that the increase in net loss was driven by the higher operating expenses and lower other income.

Looking ahead, commercial revenue is expected to increase to the range of US$100 million to US$106 million in FY 2025. This reflects growth of approximately 55% to 65%.

Pleasingly, the days of heavy losses appear to be nearly over. Management expects to generate free cash flow in the second half of FY 2025 and reach GAAP profitability during the fourth quarter.

GQG Partners Inc (ASX: GQG)

The GQG Partners share price is up over 5% to $2.50.

Investors have been buying the investment company's shares after it delivered strong profit growth in FY 2024.

For the 12 months ended 31 December, the ASX All Ords share posted a 46.9% increase in net revenue to US$760.4 million and a 50.4% jump in distributable earnings to US$447.9 million.

This allowed the ASX All Ords share to boost its total dividends by 50.2% to 13.67 US cents per share. This includes a final quarterly dividend of 3.78 US cents per share.

Commenting on the result, the company's CEO and executive director, Tim Carver, said:

We are pleased to announce our financial results. For the year ended December 31, 2024, GQG experienced net inflows of US$20.2 billion, nearly double our net flows of $10.2 billion from 2023. We ended the year with US$153.0 billion in funds under management, which reflects both net flows and investment performance, an increase of 26.9% from the end of 2023.

The growth in FUM reflects strong performance from our investment team and another great effort from our business team. The increase in FUM led to net revenue growth of 46.9% to US$760.4 million during 2024. Net operating income increased 50.4% to US$577.9 million during the same period, reflecting an increase in average funds under management partially offset by an increase in expenses as GQG continues to invest in talent and overall business activities.

Should you invest $1,000 in Avita Medical right now?

Before you buy Avita Medical shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Avita Medical wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical. The Motley Fool Australia has recommended Avita Medical. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

Man looking happy and excited as he looks at his mobile phone.
Bank Shares

NAB share price jumps on solid half year results

Investors have responded positively to the bank's results.

Read more »

Lines of codes and graphs in the background with woman looking at laptop trying to understand the data.
Earnings Results

Westpac share price sinks on half-year results miss

Let's see how the big four bank performed during the first half.

Read more »

Miner looking at a tablet.
Gold

Newmont share price lifts off on first-quarter results

The ASX 200 gold stock is charging higher on Thursday.

Read more »

A man wakes up happy with a smile on his face and arms outstretched.
Healthcare Shares

ResMed shares jump 8% on strong Q3 update

It was yet another strong quarter from this high-quality company.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Financial Shares

Up 53% in a year, why is this ASX 200 financial stock leaping higher again today?

Investors are sending the ASX 200 financial stock soaring on Wednesday. Let’s see why.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Why is this ASX 200 uranium stock rocketing 17% on Wednesday?

The ASX 200 uranium stock is racing higher today. But why?

Read more »

Piggy bank at the end of a winding road.
Dividend Investing

Why this $44 billion ASX 200 dividend stock is pushing higher today

The ASX 200 dividend stock trades on a yield of 4.6%.

Read more »

Workers inspecting a gas pipeline.
Energy Shares

Why is the Santos share price racing ahead of the ASX 200 today?

Santos shares are enjoying a day of strong outperformance. But why?

Read more »